# CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

> **NCT00908947** · NA · TERMINATED · sponsor: **C. R. Bard** · enrollment: 173 (actual)

## Conditions studied

- Superficial Femoral Artery Stenosis

## Interventions

- **DEVICE:** PTA followed by placement of LifeStent® Vascular Stent

## Key facts

- **NCT ID:** NCT00908947
- **Lead sponsor:** C. R. Bard
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2018-09-18
- **Final completion:** 2018-09-19
- **Target enrollment:** 173 (ACTUAL)
- **Why stopped:** Unable to enroll the required number of subjects
- **Last updated:** 2019-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00908947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00908947, "CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00908947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*